Metabolic surgery is specifically designed to treat Type 2 diabetes and related metabolic conditions, even in patients who are not morbidly obese. Evidence accumulated over decades shows that metabolic surgery is the most effective therapy for diabetes mellitus, delivering up to 95% resolution of Type 2 diabetes in obese patients.
The Baros team at Apollo Hospitals is one of the leading centers for diabetic surgery in India. Procedures such as Ileal Interposition have shown strong results even in non-obese patients with BMI of 27.5 and above. Most patients see significant improvement in blood sugar control within 7 days to 3 months of surgery.
Metabolic surgery works by altering the gut-hormone axis, improving insulin sensitivity and glucose metabolism at a fundamental level. The procedure is not merely about weight loss — it addresses the root metabolic dysfunction that drives Type 2 diabetes, offering a pathway to long-term remission for eligible patients.
Metabolic surgery is recommended for patients with Type 2 diabetes who have not achieved adequate control through medication and lifestyle changes, with or without significant obesity.
Metabolic surgery modifies the gut-hormone signaling pathway to fundamentally reset insulin sensitivity and glucose metabolism, not merely restrict food intake.
Surgery alters incretin hormones to improve insulin secretion and glucose regulation.
A segment of lower intestine is repositioned to enhance metabolic hormone response.
Patients experience rapid improvement in blood sugar control within days to weeks.
Regular follow-up ensures sustained diabetes remission and medication adjustment.
Metabolic surgery consistently delivers transformative results for Type 2 diabetes patients. Clinical outcomes at Baros Apollo include:
India’s leading bariatric & metabolic surgery centre at Apollo Hospitals, Chennai. Expert surgical care, proven outcomes, and lifelong support
Institute of Bariatrics, Apollo Hospitals, 21 Greams Lane, Chennai 600006